Mumbai: The US Food and Drug Administration (US FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd's plant at Karkhadi in the western state of Gujarat.The alert was issued by the US
New Delhi: Drug firm Sun Pharmaceutical Industries today said it has received final approval from the US health regulator for its generic Lansoprazole - delayed release capsules used for treating duodenal ulcer.“The United States Food
New Delhi, Aug 12: Shares of Sun Pharmaceuticals Ltd rose by 7 per cent on Monday, after the pharma major reported better than expected sales for the quarter ended June 30.As a result, top five
New Delhi, Aug 9: Sun Pharmaceutical Industries has reported a net loss of Rs 1,276.10 crore for the first quarter ended June 30, 2013, mainly on account of payment for patent litigation settlement.The company had
Hyderabad, July 22: UCB, a global biopharma company, alongwith others has filed separate cases against as many as 15 drug makers, including India's Ranbaxy, Aurobindo, Zydus, Sun Pharma, Glenmark and Alembic Pharmaceuticals for allegedly infringing
New Delhi, Dec 18: Shares of Sun Pharmaceutical Industries rose 2.5 per cent after its unit agreed to buy the generic drugs business of US-based URL Pharma from Japan's Takeda Pharmaceutical Co.This is Sun Pharma's
Washington, Sep 4: India claims the second-biggest haul after China in Asia's Fab 50 with 11 Indian companies, up from seven last year, figuring in Forbes 2012 list of 50 best publicly traded companies in
New Delhi,May 30 : Sun Pharmaceutical Industries today said it is expecting sales growth of around 20% during the current financial year, 2012-13.“For the financial year 2013 consolidated sales growth guidance is 18 to 20%
Top News
Latest News
